Circulating miR-181a as a Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction | Zendy

Jianbing Zhu | Zendy; Kang Yao | Zendy; Qian Wang | Zendy; Junjie Guo | Zendy; Hongtao Shi | Zendy; Leilei Ma | Zendy; Haibo Liu | Zendy; Wei Gao | Zendy; Yunzeng Zou | Zendy; Junbo Ge | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Circulating miR-181a as a Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction

Author(s) -

Jianbing Zhu,

Kang Yao,

Qian Wang,

Junjie Guo,

Hongtao Shi,

Leilei Ma,

Haibo Liu,

Wei Gao,

Yunzeng Zou,

Junbo Ge

Publication year - 2016

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000453209

Subject(s) - medicine , myocardial infarction , ejection fraction , unstable angina , biomarker , cardiology , troponin i , creatine kinase , troponin , creatine , receiver operating characteristic , heart failure , biology , biochemistry

In this study, we tested the hypothesis that miR-181a levels increase during acute myocardial infarction. We investigated circulating miR-181a as a potential novel biomarker for early diagnosis of acute myocardial infarction (AMI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research